PEDIATRIC H3K27M MUTANT DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) SHOWS ROBUST RESPONSE TO IMIPRIDONE BASED COMBINATION THERAPY

被引：0
|
作者：
Borsuk, Robyn [1 ]
Zhou, Lanlan [2 ,3 ]
Chang, Wen-i [1 ]
Zhang, Yiqun [2 ,3 ]
Prabhu, Varun [4 ]
Allen, Joshua [4 ]
Tapinos, Nikos [1 ]
Lulla, Rishi [1 ]
El-Deiry, Wafik [2 ,3 ]
机构：
[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Brown Univ, Providence, RI 02912 USA
[3] Lifespan Canc Inst, Providence, RI 02912 USA
[4] Oncoceutics Inc, Philadelphia, PA USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
10.1093/neuonc/noab090.106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HGG-42
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [31] SHOULD LEPTOMENINGEAL DISSEMINATION (LMD) AT DIAGNOSIS WITH AN H3K27M MUTATION BE ENOUGH TO BE CONSIDERED A DIFFUSE MIDLINE GLIOMA (DMG) H3K27M ALTERED?
    La, Janet
    McGranahan, Tresa
    NEURO-ONCOLOGY, 2022, 24 : 154 - 154
  • [32] LSD1 DEGRADATION SYNERGIZES WITH HDAC INHIBITION IN PEDIATRIC H3K27M DIFFUSE MIDLINE GLIOMA
    Haase, Rebecca
    Groves, Andrew
    Mire, Hafsa
    Qi, Jun
    Filbin, Mariella
    NEURO-ONCOLOGY, 2023, 25
  • [33] USING THE SLEEPING BEAUTY TRANSPOSASE SYSTEM TO GENERATE MOUSE MODELS OF DIFFUSE INTRINSIC PONTINE GLIOMA HARBORING ACVR1 AND H3K27M MUTATIONS
    Mendez, Flor M.
    Nunez, Felipe J.
    Koschmann, Carl
    Calinescu, Alexandra
    Saxena, Meghna
    Kamran, Neha
    Pawar, Sheeba
    Dzaman, Marta
    Lowenstein, Pedro R.
    Castro, Maria G.
    NEURO-ONCOLOGY, 2016, 18 : 209 - 209
  • [34] THE COMBINATION THERAPY OF PARP INHIBITOR AND TMZ IN DIFFUSE MIDLINE GLIOMA HARBORING H3 K27M-MUTANT
    Ohba, Shigeo
    Hashizume, Rintaro
    Hirose, Yuichi
    NEURO-ONCOLOGY, 2020, 22 : 64 - 64
  • [35] Spinal intramedullary H3K27M mutant glioma with vertebral metastasis: a case report
    Handis, Chafik
    Tanrikulu, Bahattin
    Danyeli, Ayca Ersen
    Ozek, M. Memet
    CHILDS NERVOUS SYSTEM, 2021, 37 (12) : 3933 - 3937
  • [36] Morphological Spectrum and Survival Analysis of Diffuse Midline Glioma With H3K27M Mutation
    Hassan, Usman
    Latif, Maliha
    Yousaf, Irfan
    Bin Anees, Saad
    Mushtaq, Sajid
    Akhtar, Noreen
    Loya, Asif
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [37] Spinal intramedullary H3K27M mutant glioma with vertebral metastasis: a case report
    Chafik Handis
    Bahattin Tanrıkulu
    Ayça Erşen Danyeli
    M. Memet Özek
    Child's Nervous System, 2021, 37 : 3933 - 3937
  • [38] Deep Learning for the Prediction of the Survival of Midline Diffuse Glioma with an H3K27M Alteration
    Huang, Bowen
    Chen, Tengyun
    Zhang, Yuekang
    Mao, Qing
    Ju, Yan
    Liu, Yanhui
    Wang, Xiang
    Li, Qiang
    Lei, Yinjie
    Ren, Yanming
    BRAIN SCIENCES, 2023, 13 (10)
  • [39] A PHASE I TRIAL OF PANOBINOSTAT FOLLOWING RADIATION THERAPY IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) OR H3K27M-MUTATED THALAMIC DIFFUSE MIDLINE GLIOMA (DMG): REPORT FROM THE PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC-047)
    Monje, Michelle
    Cooney, Tabitha
    Glod, John
    Huang, Jie
    Baxter, Patricia
    Vinitsky, Anna
    Kilburn, Lindsay
    Robison, Nathan J.
    Peer, Cody J.
    Figg, William D.
    Fouladi, Maryam
    Fangusaro, Jason
    Onar-Thomas, Arzu
    Dunkel, Ira J.
    Warren, Katherine E.
    NEURO-ONCOLOGY, 2022, 24 : 19 - 19
  • [40] Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma
    Duchatel, Ryan J.
    Mannan, Abdul
    Woldu, Ameha S.
    Hawtrey, Tom
    Hindley, Phoebe A.
    Douglas, Alicia M.
    Jackson, Evangeline R.
    Findlay, Izac J.
    Germon, Zacary P.
    Staudt, Dilana
    Keamey, Padraic S.
    Smith, Nathan D.
    Hindley, Kate E.
    Cain, Jason E.
    Andre, Nicolas
    La Madrid, Andres Morales
    Nixon, Brett
    De Luliis, Geoffry N.
    Nazarian, Javad
    Irish, Kathleen
    Alvaro, Frank
    Eisenstat, David D.
    Beck, Alexander
    Vitanza, Nicholas A.
    Mueller, Sabine
    Morris, Jonathan C.
    Dun, Matthew D.
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
12345